MARCHF2

RNA expression — cross-omics
Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MARCHF2 RNA expression is significantly associated with the protein abundance of many other proteins, with 16,302 significant associations in total. GBM shows the largest number of these associations.

The most reproducible MARCHF2-associated proteins across cancer lineages are NAT10, RPS3A, and CLPX. Each is linked with MARCHF2 in more than 4 cancer types. Because this analysis shows association rather than direction, both MARCHF2-to-partner and partner-to-MARCHF2 results are reported.

Each partner links to its own Q-omics profile. The scatter plot shows the strongest example, MARCHF2 versus NAT10 in BRCA, with a Pearson correlation of -0.40.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (MARCHF2→partner) and Y-score (partner→MARCHF2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCANAT10 →-0.393-0.432<.001<.00135
COADRPS3A →-0.277-0.441<.001.00235
COADCLPX →-0.268-0.555<.001<.00135
BRCAESF1_S198 →-0.556-0.503<.001<.00135
BRCARPL10A →-0.190-0.432<.001<.00135
BRCARPS3 →-0.209-0.517.001.00135
Each partner links to its Q-omics profile. Showing the 6 strongest of 16,302 associations by consensus.

MARCHF2 vs NAT10 — BRCA

Per-sample scatter of MARCHF2 vs NAT10 in BRCA (Pearson r = -0.40).

Explore this scatter interactively →

Exploration